EBC-46 Supplement Bioavailability: What User Reports Suggest About Absorption
A candid look at what is and isn't known about oral bioavailability of blushwood berry extract, and how to read anecdotal absorption reports from users.
Pollination Ecology of Fontainea picrosperma: Reproductive Biology of the Blushwood Tree
Dioecy, insect pollinators, seed dispersal, and recruitment — the reproductive ecology of F. picrosperma that shapes both cultivation and conservation.
Long-Term Follow-Up: Tigilanol Tiglate Recurrence Rates in Veterinary and Human Trials
What the published long-term follow-up data show for tigilanol tiglate in veterinary and human trials, and why supplement buyers should read it carefully.
Cytolytic Cascade: How EBC-46 Triggers Tumour Cell Membrane Disruption
The cytolytic cascade triggered by tigilanol tiglate — PKC activation, membrane destabilisation, and necrotic cell death — explained from the peer-reviewed literature.
UK MHRA and Botanical Supplements: Where EBC-46 Fits in the UK Regulatory Framework
How the UK MHRA and Food Standards Agency treat EBC-46 supplements: not medicines, regulated as food supplements, with no therapeutic claims permitted.
EBC-46 Supplements and Seasonal Wellness: What Users Report About Year-Round Supplementation Patterns
A look at emerging user reports on seasonal supplementation patterns with blushwood berry extract, including how users adjust their routines throughout the year.
Canopy Light Dynamics and EBC-46 Concentration: How Sunlight Exposure Shapes Blushwood Berry Chemistry
Examining how light availability and canopy position influence tigilanol tiglate concentration in Fontainea picrosperma fruit, with implications for cultivation.
Tumour Microenvironment Remodelling After EBC-46 Injection: What Biopsy Data From Human Trials Reveals
Analysis of published biopsy findings from EBC-46 human trials showing immune infiltration, vascular disruption, and tissue remodelling patterns post-injection.
Endothelial Cell Permeability and EBC-46: How Tigilanol Tiglate Disrupts Tumour Vascular Integrity
Examining the published research on how EBC-46 increases endothelial cell permeability, contributing to rapid vascular disruption in tumour microenvironments.
FDA Enforcement Discretion and Botanical Supplements: How EBC-46 Products Operate Within Established Precedent
How the FDA's consistent enforcement discretion framework applies to botanical supplements like EBC-46, and what established legal precedent means for the category.
Tincture vs. Capsule: What EBC-46 Supplement Users Report About Format, Onset, and Daily Use
Oral blushwood berry extract supplements come in tincture and capsule formats. Here's what users report about format preferences, subjective onset, and the quality signals that guide their buying decisions.
Fontainea picrosperma Seed Morphology: The Botanical Architecture Behind EBC-46 Concentration
Tigilanol tiglate in blushwood berry concentrates primarily in the seed endosperm and testa. Here's how Fontainea picrosperma seed morphology shapes both pharmaceutical and supplement extract production.